 | • レポートコード：QYR2104Z5020 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、網膜障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（加齢性黄斑変性症、糖尿病性網膜症、眼炎症性疾患（ブドウ膜炎）、黄斑円孔）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・網膜障害治療の市場動向 ・企業の競争状況、市場シェア ・網膜障害治療の種類別市場規模（加齢性黄斑変性症、糖尿病性網膜症、眼炎症性疾患（ブドウ膜炎）、黄斑円孔） ・網膜障害治療の用途別市場規模（病院、診療所、その他） ・網膜障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・網膜障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・網膜障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・網膜障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・網膜障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ALLERGAN、AbbVie、Alimera Sciences、Janssen Biotech、Swedish Orphan Biovitrum、Roche、Bristol-Myers Squibb、Genzyme、Genentech、OCULAR THERAPEUTIX、Bausch & Lomb、UCBCares） ・結論 |
Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectious retinitis, macular edema, macular hole, retinoblastoma, retinal degeneration, retinoschisis and uveitis etc. There are various types of retinal disorders but most of them cause visual symptoms.
Market Analysis and Insights: Global Retinal Disorders Therapy Market
The global Retinal Disorders Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Disorders Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Disorders Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Disorders Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Disorders Therapy market.
Global Retinal Disorders Therapy Scope and Market Size
Retinal Disorders Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Disorders Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Age Related Macular Degeneration
Diabetic Retinopathy
Ocular Inflammatory Disease (Uveitis)
Macular Hole
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
ALLERGAN
AbbVie
Alimera Sciences
Janssen Biotech
Swedish Orphan Biovitrum
Roche
Bristol-Myers Squibb
Genzyme
Genentech
Janssen Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disorders Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Market by Application
1.3.1 Global Retinal Disorders Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Retinal Disorders Therapy Market Perspective (2016-2027)
2.2 Retinal Disorders Therapy Growth Trends by Regions
2.2.1 Retinal Disorders Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Disorders Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Disorders Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Disorders Therapy Industry Dynamic
2.3.1 Retinal Disorders Therapy Market Trends
2.3.2 Retinal Disorders Therapy Market Drivers
2.3.3 Retinal Disorders Therapy Market Challenges
2.3.4 Retinal Disorders Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Retinal Disorders Therapy Players by Revenue
3.1.1 Global Top Retinal Disorders Therapy Players by Revenue (2016-2021)
3.1.2 Global Retinal Disorders Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Disorders Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Disorders Therapy Revenue
3.4 Global Retinal Disorders Therapy Market Concentration Ratio
3.4.1 Global Retinal Disorders Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disorders Therapy Revenue in 2020
3.5 Retinal Disorders Therapy Key Players Head office and Area Served
3.6 Key Players Retinal Disorders Therapy Product Solution and Service
3.7 Date of Enter into Retinal Disorders Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Retinal Disorders Therapy Breakdown Data by Type
4.1 Global Retinal Disorders Therapy Historic Market Size by Type (2016-2021)
4.2 Global Retinal Disorders Therapy Forecasted Market Size by Type (2022-2027)
5 Retinal Disorders Therapy Breakdown Data by Application
5.1 Global Retinal Disorders Therapy Historic Market Size by Application (2016-2021)
5.2 Global Retinal Disorders Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Retinal Disorders Therapy Market Size (2016-2027)
6.2 North America Retinal Disorders Therapy Market Size by Type
6.2.1 North America Retinal Disorders Therapy Market Size by Type (2016-2021)
6.2.2 North America Retinal Disorders Therapy Market Size by Type (2022-2027)
6.2.3 North America Retinal Disorders Therapy Market Size by Type (2016-2027)
6.3 North America Retinal Disorders Therapy Market Size by Application
6.3.1 North America Retinal Disorders Therapy Market Size by Application (2016-2021)
6.3.2 North America Retinal Disorders Therapy Market Size by Application (2022-2027)
6.3.3 North America Retinal Disorders Therapy Market Size by Application (2016-2027)
6.4 North America Retinal Disorders Therapy Market Size by Country
6.4.1 North America Retinal Disorders Therapy Market Size by Country (2016-2021)
6.4.2 North America Retinal Disorders Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Retinal Disorders Therapy Market Size (2016-2027)
7.2 Europe Retinal Disorders Therapy Market Size by Type
7.2.1 Europe Retinal Disorders Therapy Market Size by Type (2016-2021)
7.2.2 Europe Retinal Disorders Therapy Market Size by Type (2022-2027)
7.2.3 Europe Retinal Disorders Therapy Market Size by Type (2016-2027)
7.3 Europe Retinal Disorders Therapy Market Size by Application
7.3.1 Europe Retinal Disorders Therapy Market Size by Application (2016-2021)
7.3.2 Europe Retinal Disorders Therapy Market Size by Application (2022-2027)
7.3.3 Europe Retinal Disorders Therapy Market Size by Application (2016-2027)
7.4 Europe Retinal Disorders Therapy Market Size by Country
7.4.1 Europe Retinal Disorders Therapy Market Size by Country (2016-2021)
7.4.2 Europe Retinal Disorders Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Retinal Disorders Therapy Market Size (2016-2027)
8.2 Asia-Pacific Retinal Disorders Therapy Market Size by Type
8.2.1 Asia-Pacific Retinal Disorders Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Disorders Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Disorders Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Disorders Therapy Market Size by Application
8.3.1 Asia-Pacific Retinal Disorders Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Disorders Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Disorders Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Disorders Therapy Market Size by Region
8.4.1 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Disorders Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Retinal Disorders Therapy Market Size (2016-2027)
9.2 Latin America Retinal Disorders Therapy Market Size by Type
9.2.1 Latin America Retinal Disorders Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Disorders Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Disorders Therapy Market Size by Type (2016-2027)
9.3 Latin America Retinal Disorders Therapy Market Size by Application
9.3.1 Latin America Retinal Disorders Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Disorders Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Disorders Therapy Market Size by Application (2016-2027)
9.4 Latin America Retinal Disorders Therapy Market Size by Country
9.4.1 Latin America Retinal Disorders Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Disorders Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Retinal Disorders Therapy Market Size (2016-2027)
10.2 Middle East & Africa Retinal Disorders Therapy Market Size by Type
10.2.1 Middle East & Africa Retinal Disorders Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Disorders Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Disorders Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Disorders Therapy Market Size by Application
10.3.1 Middle East & Africa Retinal Disorders Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Disorders Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Disorders Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Disorders Therapy Market Size by Country
10.4.1 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Disorders Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Details
11.1.2 ALLERGAN Business Overview
11.1.3 ALLERGAN Retinal Disorders Therapy Introduction
11.1.4 ALLERGAN Revenue in Retinal Disorders Therapy Business (2016-2021)
11.1.5 ALLERGAN Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Retinal Disorders Therapy Introduction
11.2.4 AbbVie Revenue in Retinal Disorders Therapy Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 Alimera Sciences
11.3.1 Alimera Sciences Company Details
11.3.2 Alimera Sciences Business Overview
11.3.3 Alimera Sciences Retinal Disorders Therapy Introduction
11.3.4 Alimera Sciences Revenue in Retinal Disorders Therapy Business (2016-2021)
11.3.5 Alimera Sciences Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Details
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Retinal Disorders Therapy Introduction
11.4.4 Janssen Biotech Revenue in Retinal Disorders Therapy Business (2016-2021)
11.4.5 Janssen Biotech Recent Development
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Company Details
11.5.2 Swedish Orphan Biovitrum Business Overview
11.5.3 Swedish Orphan Biovitrum Retinal Disorders Therapy Introduction
11.5.4 Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2016-2021)
11.5.5 Swedish Orphan Biovitrum Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Retinal Disorders Therapy Introduction
11.6.4 Roche Revenue in Retinal Disorders Therapy Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Retinal Disorders Therapy Introduction
11.7.4 Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Genzyme
11.8.1 Genzyme Company Details
11.8.2 Genzyme Business Overview
11.8.3 Genzyme Retinal Disorders Therapy Introduction
11.8.4 Genzyme Revenue in Retinal Disorders Therapy Business (2016-2021)
11.8.5 Genzyme Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Retinal Disorders Therapy Introduction
11.9.4 Genentech Revenue in Retinal Disorders Therapy Business (2016-2021)
11.9.5 Genentech Recent Development
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Company Details
11.10.2 OCULAR THERAPEUTIX Business Overview
11.10.3 OCULAR THERAPEUTIX Retinal Disorders Therapy Introduction
11.10.4 OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2016-2021)
11.10.5 OCULAR THERAPEUTIX Recent Development
11.11 Bausch & Lomb
11.11.1 Bausch & Lomb Company Details
11.11.2 Bausch & Lomb Business Overview
11.11.3 Bausch & Lomb Retinal Disorders Therapy Introduction
11.11.4 Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2016-2021)
11.11.5 Bausch & Lomb Recent Development
11.12 UCBCares
11.12.1 UCBCares Company Details
11.12.2 UCBCares Business Overview
11.12.3 UCBCares Retinal Disorders Therapy Introduction
11.12.4 UCBCares Revenue in Retinal Disorders Therapy Business (2016-2021)
11.12.5 UCBCares Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Retinal Disorders Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Age Related Macular Degeneration
Table 3. Key Players of Diabetic Retinopathy
Table 4. Key Players of Ocular Inflammatory Disease (Uveitis)
Table 5. Key Players of Macular Hole
Table 6. Global Retinal Disorders Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Retinal Disorders Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinal Disorders Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Retinal Disorders Therapy Market Share by Regions (2016-2021)
Table 10. Global Retinal Disorders Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Retinal Disorders Therapy Market Share by Regions (2022-2027)
Table 12. Retinal Disorders Therapy Market Trends
Table 13. Retinal Disorders Therapy Market Drivers
Table 14. Retinal Disorders Therapy Market Challenges
Table 15. Retinal Disorders Therapy Market Restraints
Table 16. Global Retinal Disorders Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Retinal Disorders Therapy Market Share by Players (2016-2021)
Table 18. Global Top Retinal Disorders Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorders Therapy as of 2020)
Table 19. Ranking of Global Top Retinal Disorders Therapy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Retinal Disorders Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disorders Therapy Product Solution and Service
Table 23. Date of Enter into Retinal Disorders Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disorders Therapy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Retinal Disorders Therapy Revenue Market Share by Type (2016-2021)
Table 27. Global Retinal Disorders Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Retinal Disorders Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Retinal Disorders Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Retinal Disorders Therapy Revenue Market Share by Application (2016-2021)
Table 31. Global Retinal Disorders Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Retinal Disorders Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Retinal Disorders Therapy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Retinal Disorders Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Retinal Disorders Therapy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Retinal Disorders Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Retinal Disorders Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Retinal Disorders Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Retinal Disorders Therapy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Retinal Disorders Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Retinal Disorders Therapy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Retinal Disorders Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Retinal Disorders Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Retinal Disorders Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retinal Disorders Therapy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retinal Disorders Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retinal Disorders Therapy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Retinal Disorders Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Retinal Disorders Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Retinal Disorders Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Retinal Disorders Therapy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Retinal Disorders Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Retinal Disorders Therapy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Retinal Disorders Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Retinal Disorders Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Retinal Disorders Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retinal Disorders Therapy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retinal Disorders Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retinal Disorders Therapy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Retinal Disorders Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Retinal Disorders Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Retinal Disorders Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 63. ALLERGAN Company Details
Table 64. ALLERGAN Business Overview
Table 65. ALLERGAN Retinal Disorders Therapy Product
Table 66. ALLERGAN Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 67. ALLERGAN Recent Development
Table 68. AbbVie Company Details
Table 69. AbbVie Business Overview
Table 70. AbbVie Retinal Disorders Therapy Product
Table 71. AbbVie Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 72. AbbVie Recent Development
Table 73. Alimera Sciences Company Details
Table 74. Alimera Sciences Business Overview
Table 75. Alimera Sciences Retinal Disorders Therapy Product
Table 76. Alimera Sciences Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 77. Alimera Sciences Recent Development
Table 78. Janssen Biotech Company Details
Table 79. Janssen Biotech Business Overview
Table 80. Janssen Biotech Retinal Disorders Therapy Product
Table 81. Janssen Biotech Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 82. Janssen Biotech Recent Development
Table 83. Swedish Orphan Biovitrum Company Details
Table 84. Swedish Orphan Biovitrum Business Overview
Table 85. Swedish Orphan Biovitrum Retinal Disorders Therapy Product
Table 86. Swedish Orphan Biovitrum Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 87. Swedish Orphan Biovitrum Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Retinal Disorders Therapy Product
Table 91. Roche Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Bristol-Myers Squibb Company Details
Table 94. Bristol-Myers Squibb Business Overview
Table 95. Bristol-Myers Squibb Retinal Disorders Therapy Product
Table 96. Bristol-Myers Squibb Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Genzyme Company Details
Table 99. Genzyme Business Overview
Table 100. Genzyme Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 101. Genzyme Recent Development
Table 102. Genentech Company Details
Table 103. Genentech Business Overview
Table 104. Genentech Retinal Disorders Therapy Product
Table 105. Genentech Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 106. Genentech Recent Development
Table 107. OCULAR THERAPEUTIX Company Details
Table 108. OCULAR THERAPEUTIX Business Overview
Table 109. OCULAR THERAPEUTIX Retinal Disorders Therapy Product
Table 110. OCULAR THERAPEUTIX Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 111. OCULAR THERAPEUTIX Recent Development
Table 112. Bausch & Lomb Company Details
Table 113. Bausch & Lomb Business Overview
Table 114. Bausch & Lomb Retinal Disorders Therapy Product
Table 115. Bausch & Lomb Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 116. Bausch & Lomb Recent Development
Table 117. UCBCares Company Details
Table 118. UCBCares Business Overview
Table 119. UCBCares Retinal Disorders Therapy Product
Table 120. UCBCares Revenue in Retinal Disorders Therapy Business (2016-2021) & (US$ Million)
Table 121. UCBCares Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disorders Therapy Market Share by Type: 2020 VS 2027
Figure 2. Age Related Macular Degeneration Features
Figure 3. Diabetic Retinopathy Features
Figure 4. Ocular Inflammatory Disease (Uveitis) Features
Figure 5. Macular Hole Features
Figure 6. Global Retinal Disorders Therapy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Retinal Disorders Therapy Report Years Considered
Figure 11. Global Retinal Disorders Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Retinal Disorders Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Retinal Disorders Therapy Market Share by Regions: 2020 VS 2027
Figure 14. Global Retinal Disorders Therapy Market Share by Regions (2022-2027)
Figure 15. Global Retinal Disorders Therapy Market Share by Players in 2020
Figure 16. Global Top Retinal Disorders Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disorders Therapy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Retinal Disorders Therapy Revenue in 2020
Figure 18. Global Retinal Disorders Therapy Revenue Market Share by Type (2016-2021)
Figure 19. Global Retinal Disorders Therapy Revenue Market Share by Type (2022-2027)
Figure 20. North America Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Retinal Disorders Therapy Market Share by Type (2016-2027)
Figure 22. North America Retinal Disorders Therapy Market Share by Application (2016-2027)
Figure 23. North America Retinal Disorders Therapy Market Share by Country (2016-2027)
Figure 24. United States Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinal Disorders Therapy Market Share by Type (2016-2027)
Figure 28. Europe Retinal Disorders Therapy Market Share by Application (2016-2027)
Figure 29. Europe Retinal Disorders Therapy Market Share by Country (2016-2027)
Figure 30. Germany Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinal Disorders Therapy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Retinal Disorders Therapy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Retinal Disorders Therapy Market Share by Region (2016-2027)
Figure 40. China Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinal Disorders Therapy Market Share by Type (2016-2027)
Figure 48. Latin America Retinal Disorders Therapy Market Share by Application (2016-2027)
Figure 49. Latin America Retinal Disorders Therapy Market Share by Country (2016-2027)
Figure 50. Mexico Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinal Disorders Therapy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Retinal Disorders Therapy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Retinal Disorders Therapy Market Share by Country (2016-2027)
Figure 56. Turkey Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Retinal Disorders Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. ALLERGAN Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 60. AbbVie Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 61. Alimera Sciences Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 62. Janssen Biotech Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 63. Swedish Orphan Biovitrum Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 66. Genzyme Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 67. Genentech Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 68. OCULAR THERAPEUTIX Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 69. Bausch & Lomb Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 70. UCBCares Revenue Growth Rate in Retinal Disorders Therapy Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の網膜症治療市場 2021：企業別、地域別、種類・用途別 The Retinal Disorders Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…- 世界の黄斑変性症（AMD）・その他網膜疾患市場規模・現状・予測（2021年-2027年） Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands. Market Analysis and Insights: Global…
- 世界の加齢性黄斑変性症向け遺伝子治療市場規模・現状・予測（2021年-2027年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- 世界の黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬市場規模・現状・予測（2021年-2027年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 世界の加齢黄斑変性症（AMD）市場規模・現状・予測（2021年-2027年） Age related macular degeneration (AMD) is a condition wherein the macula the small central area of the retina in the eye is deteriorated. Market Analysis and Insights: Global Age Related Macular Degeneration (AMD) Market The global Age Related Macular Degeneration (AMD) market size is projected to r…